Cardinal Health - CAH Stock Forecast, Price & News

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last twelve months. There are currently 8 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CAH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CAH, but not buy additional shares or sell existing shares.
View CAH analyst ratings or view top-rated stocks.

11 Wall Street research analysts have issued twelve-month price objectives for Cardinal Health's stock. Their CAH share price forecasts range from $67.00 to $86.00. On average, they anticipate the company's share price to reach $76.82 in the next twelve months. This suggests that the stock has a possible downside of 0.5%.
View analysts price targets for CAH or view top-rated stocks among Wall Street analysts.

Cardinal Health's stock was trading at $76.87 at the beginning of 2023. Since then, CAH shares have increased by 0.5% and is now trading at $77.24.
View the best growth stocks for 2023 here.

Cardinal Health saw a decline in short interest in January. As of January 15th, there was short interest totaling 5,480,000 shares, a decline of 23.2% from the December 31st total of 7,140,000 shares. Based on an average trading volume of 3,040,000 shares, the days-to-cover ratio is presently 1.8 days. Currently, 2.1% of the company's shares are short sold.
View Cardinal Health's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 2nd 2023.
View our CAH earnings forecast.

Cardinal Health will be holding an earnings conference call on Thursday, February 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

Cardinal Health, Inc. (NYSE:CAH) posted its quarterly earnings data on Friday, November, 4th. The company reported $1.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.96 by $0.24. The company earned $49.60 billion during the quarter, compared to the consensus estimate of $46.88 billion. Cardinal Health had a negative trailing twelve-month return on equity of 252.82% and a negative net margin of 0.59%.

Cardinal Health declared a quarterly dividend on Tuesday, November 8th. Shareholders of record on Tuesday, January 3rd will be given a dividend of $0.4957 per share on Sunday, January 15th. This represents a $1.98 dividend on an annualized basis and a dividend yield of 2.57%. The ex-dividend date of this dividend is Friday, December 30th.
Read our dividend analysis for CAH.

Cardinal Health (NYSE:CAH) pays an annual dividend of $1.98 per share and currently has a dividend yield of 2.59%. The company has been increasing its dividend for 37 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 32.35%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CAH will have a dividend payout ratio of 32.09% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CAH.

Cardinal Health issued an update on its FY 2023 earnings guidance on Friday, November, 18th. The company provided earnings per share guidance of $5.05-$5.40 for the period, compared to the consensus estimate of $5.24. The company issued revenue guidance of -.

357 employees have rated Cardinal Health Chief Executive Officer Mike Kaufmann on Glassdoor.com. Mike Kaufmann has an approval rating of 85% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Pfizer (PFE), Chevron (CVX), Intel (INTC), Cisco Systems (CSCO) and PepsiCo (PEP).

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (0.34%), New York State Common Retirement Fund (0.30%), Wedge Capital Management L L P NC (0.19%), Capital Investment Advisors LLC (0.13%), New York State Teachers Retirement System (0.11%) and Natixis Advisors L.P. (0.09%). Insiders that own company stock include Michelle Brennan and Ola M Snow.
View institutional ownership trends.

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CAH stock can currently be purchased for approximately $77.24.

Cardinal Health (NYSE:CAH) has a market capitalization of $20.25 billion and generates $181.36 billion in revenue each year. The company earns $-933,000,000.00 in net income (profit) each year or $6.12 on an earnings per share basis.

The company employs 46,500 workers across the globe.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The official website for the company is www.cardinalhealth.com. The company can be reached via phone at (614) 757-5000, via email at investor.relations@cardinalhealth.com, or via fax at 614-757-6000.